title: Lung cancer in 2010: One size does not fit all.
abstract: Advances in non-small-cell lung cancer over the past decade have resulted in new treatments with minimal toxic effects and dramatic clinical benefits. 2010 saw continued advancement in our understanding of the molecular genetics of lung cancer and of specific targeted inhibitors with remarkable clinical benefit in selected populations.
authors.affiliation: Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Preston Research Building 685, Nashville, TN 37232, USA.
authors.forename: Christine M
authors.initials: CM
authors.lastname: Lovly
authors.forename: David P
authors.initials: DP
authors.lastname: Carbone
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor